Immunology - Cancers - Blood Cells Flashcards
What is a Granulocyte?
“NMEB”
♣️
Granulocytes are a category of white blood cells WBC characterized by the presence of GRANULES in their cytoplasm. They are also called POLYMORPHONUCLEAR leukocytes or polymorphonuclear neutrophils (PMN, PML, or PMNL) because of the varying shapes of the nucleus, which is usually lobed into TWO TO FOUR segments. This DISTINGUISHES them from the mononuclear agranulocytes.
♣️
Polymorphonuclear leukocyte often refers specifically to NEUTROPHIL granulocytes,
EOSINOPHILS, BASOPHILS, and MAST cells
“NMEB”
Granulocytes are produced via granulopoiesis in the BONE MARROW
Name the 5 types of LEUKOCYTES? (WBC)
3/2
♣️♣️♣️♦️♦️
There are FIVE types of white blood cells.
neutrophils, ♣️ eosinophils, ♣️ basophils, ♣️ and lymphocytes, ♦️ monocytes. ♦️
These five types are in two main groups: The Granulocytes and The Mononuclear Cells.
What is a MONOCYTE?
♦️
MONOCYTES
WBC
Monocytes are amoeboid in appearance, and have NON-GRANULATED cytoplasm. thus are classified as AGRANULOCYTES.
Monocytes share the PHAGOCYTOSIS function of neutrophils, but are much longer lived as they have an additional role: they PRESENT PIECES of pathogens to T cells so that the pathogens may be recognized again and killed, or so that an antibody response may be mounted
MACROPHAGES
DENDRITIC CELLS
In an adult human, half of the monocytes are stored in the SPLEEN. These change into macrophages after entering into appropriate tissue spaces.
MONOCYTE ➡️ MACROPHAGE in TISSUE
What is an AGRANULOCYTE?
♦️♦️
AGRANULOCYTES (nongranulocytes, mononuclear leukocytes)
The TWO TYPES of agranulocytes in the blood circulation are LYMPHOCYTES and MONOCYTES. ♦️♦️
These make up about 35% of the hematologic BLOOD VALUE.
A THIRD TYPE of agranulocyte, the macrophage, is FORMED IN THE TISSUE when monocytes leave the circulation and differentiate into MACROPHAGES.
What is a MAST CELL?
⛵️🔗
Granulocyte: (MCHHAA)
A MAST CELL ⛵️ is a migrant cell of connective tissue that contains many GRANULES rich in HISTAMINE and HEPARIN.
Has Histamine receptors which anti-histamine drugs bind 🔗to
Specifically, it is a type of granulocyte derived from the MYLOID STEM cell that is a part of the immune and neuroimmune systems.
Best known for their role in ALLEGY and ANAPHYLAXIS.
Mast cells play an important PROTECTIVE ROLE as well, being intimately involved in wound healing, angiogenesis, immune tolerance, defense against pathogens, and blood–brain barrier function.
How do ANTI-HISTAMINES work?
🔗🔗
TWO SUBTYPES: H1 and H2 🔗🔗
H1-antihistamines work by BINDING to histamine H1 RECEPTORS in MAST CELLS, SMOOTH MUSCLE , and ENDOTHELIUM in the body as well as in the tuberomammillary nucleus in the brain.
- Allergic reactions in the nose
- Insomnia
- Vertigo caused by problems with the inner ear
H2-antihistamines BIND to histamine H2 RECEPTORS in the UPPER G.I. TRACT primarily in the STOMACH. Antihistamines that target the histamine H2-receptor are used to treat gastric acid conditions.
- Peptic ulcers
- Acid reflux
What is an ANTIGEN 👹
ANTIGEN 👹
a TOXIN or other FORIEGN SUBSTANCE which induces an immune response in the body, especially the production of antibodies.
- Antigens are “targeted” by antibodies.
- The antigen may originate from within the body (“self-antigen”) AUTOIMMUNE or from the external environment (“non-self”).
- VACCINES are examples of antigens in an immunogenic form, which are intentionally administered to a recipient to induce the memory function of adaptive immune system
What is a LYSOSOME?
LYSOSOME
A membrane-bound organelle found in many animal cells. They are spherical VESICLES that contain HYDROLYTIC ENZYMES that can break down many kinds of biomolecules.
Vesicles are small spheres of fluid surrounded by a lipid bilayer membrane, and they have roles in transporting molecules within the cell.
There are 50 to 1,000 lysosomes per mammalian cell.
What is the ATOPIC TRIAD?
ATOPIC TRIAD 80%
Asthma
Eczema
Allergies
“AAE…”
It’s called the atopic triad because they so often occur together. Up to 80% of children with ECZEMA also have asthma or allergies to pollen, dust mites, pet dander, mold, or certain foods.
What is the normal range for Total Leukocyte Count? (TLC or WBC)
⚪️⚪️⚪️
💰
⚪️⚪️4000-11,000 mm3 ⚪️⚪️
Leukopenia < 4000-11,000 > Leukocytosis
Normal PEDIATRIC ranges may go higher
- The NUMBER of leukocytes in the blood is often an INDICATOR OF DISEASE, and thus the white blood cell count is an important subset of the complete blood count.
- White blood cells make up approximately 1% 💰of the TOTAL BLOOD VOLUME in a healthy ADULT, making them substantially less numerous than the red blood cells at 40% to 45%.
Where does Leukemia begin?
Leukemia begins in the BONE MARROW, which is where new blood cells are made. The symptoms of leukemia are often caused by problems in the bone marrow.
As LEUKEMIA CELLS build up in the marrow, they can CROWD OUT the NORMAL BLOOD CELLS. As a result, a child may not have enough normal red blood cells, white blood cells, and blood platelets. These SHORTAGES show up on blood tests, but they can also cause symptoms. The leukemia cells might also invade other areas of the body, which can also cause symptoms.
Acute Lymphocytic Leukemia (ALL) prevalences?
ACUTE LYMPHOCYTIC LEUKEMIA:
-MOST common cancer in CHILDREN 0-14 years old (26% of all cancers for age group)
- 80% of Leukemia cases in Children
- 56% of Leukemia cases in Adolescents
PEAK incidence: 2-4 years old.
Substantially higher in WHITE children.
5 year survival rate: 90%
Acute Lymphocytic Leukemia (ALL) pathology?
The cancerous cell in ALL is the LYMPHOBLAST. Normal lymphoblasts develop into mature, infection-fighting B-cells or T-cells, also called lymphocytes.
ALL emerges when a single lymphoblast gains many MUTATIONS TO GENES that affect blood cell development and proliferation. In childhood ALL, this process BEGINS AT CONCEPTION with the inheritance of some of these genes.
A BONE MARROW BIOPSY provides conclusive proof of ALL, typically with >20% of all cells being leukemic LYMPHOBLASTS.
What is HCT?
Why is it important to Pediatric Dentists?
HTC
Hematopoietic Cell Transplant
The American Academy of Pediatric Dentistry (AAPD) recognizes that the pediatric dental professional plays an important role in the diagnosis, prevention, stabilization, and treatment of oral and dental problems that can COMPROMISE the child’s quality of life before, during, and after immuno-suppressive therapy which lowers the body’s normal immune response. This can be deliberate as in lowering the immune response to PREVENT the REJECTION of an organ or hematopoietic cell TRANSPLANT (HCT)
Patients with a compromised immune system may not be able to tolerate a transient BACTEREMIA following invasive dental procedures.
Hematological considerations for ANC, Antibiotics, and Dental Treatment.
⚪️⚪️
ABSOLUTE NEUTROPHIL COUNT (ANC)
— >2,000 ⚪️⚪️ per cubic millimeters (/mm3): NO need for antibiotic prophylaxis
— 1000 to 2000/mm3: Use clinical judgment based on the patient’s health status and planned procedures. If infection is present or unclear, more aggressive antibiotic therapy may be indicated and should be discussed with the medical team
— <1,000/mm3: defer elective dental care.
In dental emergency cases, discuss antibiotic coverage (antibiotic prophylaxis versus antibiotic coverage for a period of time) with medical team before proceeding with treatment. The patient may need hospitalization for dental management
Hematological considerations for Platelet Count, Transfusions, and Dental Treatment.
👨🎤 “the 1975”
PLATELET COUNT
— >75,000/mm3: no additional support needed; 👨🎤
— 40,000 to 75,000/mm3: platelet transfusions may be considered pre- and 24 hours post-operatively. Localized procedures to manage prolonged bleeding may include sutures, hemostatic agents, pressure packs, and/ or gelatin foams; and
— <40,000/mm3: defer care.
In dental emergency cases, contact the patient’s physician to discuss supportive measures (e.g., platelet transfusions, bleeding control, hospital admission and care) before proceeding. In addition, localized procedures (e.g., microfibrillar collagen, topical thrombin) and additional medications as recommended by the hematologist/oncologist (e.g., aminocaproic acid, tranexamic acid) may help control bleeding.